Osteoporosis
Osteoporosis is a systemic skeletal disease characterized by reduced bone strength and increased susceptibility to fragility fractures.
Osteoporosis is a systemic skeletal disease characterized by reduced bone strength and increased susceptibility to fragility fractures. Bone strength depends on both bone mineral density and the quality, architecture, and turnover of bone tissue. The condition develops when bone resorption by osteoclasts exceeds bone formation by osteoblasts over time, disrupting normal bone remodeling. Loss of trabecular and cortical bone may occur without symptoms until a fracture develops, commonly involving the vertebrae, hip, wrist, or proximal humerus.
Bone remodeling is regulated by mechanical loading, calcium and vitamin D availability, endocrine signals, and local molecular pathways. Osteoclastogenesis is promoted primarily through receptor activator of NF-κB ligand signaling, whereas osteoblast differentiation and matrix production involve factors including RUNX family transcription factor 2 and osteocalcin. Alkaline phosphatase is a marker associated with osteoblast activity and mineralization. oxidative stress, including reactive oxygen species and changes in Superoxide Dismutase (SOD) activity, may also influence bone-cell function. Osteoporosis is particularly common with advancing age and estrogen deficiency after menopause, although low body mass index, limited physical activity, nutritional deficiencies, certain medications, and other diseases can contribute.
Diagnosis commonly incorporates clinical fracture risk assessment and measurement of bone mineral density, usually by dual-energy X-ray absorptiometry. osteopenia denotes bone density below the young-adult reference range but not low enough to meet the conventional densitometric definition of osteoporosis; regional osteopenia can also occur in localized disorders. Management includes weight-bearing and resistance exercise, fall prevention, adequate calcium and vitamin D intake, and pharmacological treatment when fracture risk is sufficiently high. Antiresorptive therapies include bisphosphonates and denosumab, while anabolic or bone-forming approaches include teriparatide, abaloparatide, and romosozumab. The overall therapeutic objective is to reduce fracture risk while maintaining or improving bone strength.
Where the papers sit
10 papers from the last 6 months study osteoporosis directly · updated from PubMed 5 Nov 2026
Study type 0 clinical trials · 3 observational · 3 human data · 2 preclinical · 2 unclassified
Themes 3 themes · 1 new direction
-
Bone Health Prevention and Detection
Osteoporosis research is combining dietary prevention, natural compounds, bone-targeted mRNA delivery, automated imaging, and plasma-protein prediction. Anti-sclerostin antibody mRNA and naringin aim to improve bone remodeling, while DenseNet-based radiographs and explainable machine learning pursue earlier detection and prognosis. The work is moving toward targeted therapies and scalable, interpretable screening rather than single-measure assessment. Fracture fixation complications remain a related clinical endpoint, underscoring the need to connect bone quality with outcomes.
6 papers · 60%
-
Biologic Access and Biomarkers
Denosumab biosimilars are being assessed as a lower-cost route to osteoporosis treatment, while multi-omic work seeks stress-related biomarkers for diagnosis and therapy selection. Work is moving along complementary tracks of affordability analysis and biologic characterization. Evidence remains early: one study is a regional budget-impact model in Malaysia and Thailand, while the other focuses on biomarker discovery rather than validation. No unified treatment strategy has yet emerged.
2 papers · 20%
-
CT Screening Before Spine Surgery
qCT-based screening is being refined to identify osteoporosis and osteopenia before lumbar fusion surgery. Trabecular attenuation at the first lumbar vertebra is used as a surrogate for bone mineral density and impaired bone quality. The main unresolved question is which age thresholds and sensitivity targets best identify patients at risk before higher-risk procedures. This work is moving toward procedure-specific screening criteria rather than universal age-based assessment.
2 papers · 20%
Osteoporosis is framed as a health-system affordability and access problem
The biosimilar-denosumab study in Malaysia and Thailand treats osteoporosis not only as a disease requiring therapy but as a driver of national healthcare expenditure and treatment access, modeling whether replacing reference denosumab with a lower-cost biosimilar changes five-year payer budgets. This introduces a health-economic and policy role for osteoporosis that is distinct from the set’s otherwise clinical, biological, diagnostic, preventive, and prognostic uses 42593584Aug.
Papers
The 10 papers from the last 6 months that study osteoporosis directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Bone Health Prevention and Detection (6)
- OsteoNet-X: A deep residual learning framework for automated osteoporosis detection from knee X-ray images. PloS one · 27 Oct 2026 PMID 42945347
- Naringin attenuates orchidectomy-induced bone loss in male rats: evidence from bone remodeling and telomere-related indices. Journal of molecular histology · 10 Sept 2026 PMID 42717104
- Explainable Plasma Proteomics-Based Machine Learning for Osteoporosis Diagnosis, Prognosis, and Protein Biomarker Discovery in the UK Biobank. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 29 Aug 2026 PMID 42667149
- Complications and risk factors following volar locking plate fixation of distal radius fractures: A 2-institution retrospective study. Medicine · 18 Jul 2026 PMID 42470049
- BHOD: a bone health optimized dietary pattern designed for osteoporosis prevention. NPJ science of food · 1 Jul 2026 PMID 42386741
- Engineering Bone-Targeted LNP Delivery of Anti-Sclerostin Antibody mRNA for the Treatment of Osteoporosis. Journal of biomedical materials research. Part A · 24 Jun 2026 PMID 42338194
Biologic Access and Biomarkers (2)
- Osteoporosis treatment with biosimilars in Malaysia and Thailand: a budget impact analysis. Archives of osteoporosis · 13 Aug 2026 PMID 42593584
- Identification of Chronic Stress-Related Biomarkers for Potential Diagnosis and Treatment of Osteoporosis: An Integrated Multi-omic and Clinical Data Analysis. Therapeutic innovation & regulatory science · 9 Jun 2026 PMID 42265416
CT Screening Before Spine Surgery (2)
- What are the Optimal Age Thresholds for qCT-Based Osteoporosis and Osteopenia Screening in Patients Undergoing Lumbar Fusion Surgery? Spine · 16 Jun 2026 PMID 42302175
- Computed tomography-measured trabecular attenuation at first lumbar vertebra as a surrogate marker of bone mineral density and osteoporosis in patients undergoing hemodialysis. Renal failure · 20 May 2026 PMID 42161888
By study type
Observational studies and case reports (3)
- Complications and risk factors following volar locking plate fixation of distal radius fractures: A 2-institution retrospective study. Medicine · 18 Jul 2026 PMID 42470049
- What are the Optimal Age Thresholds for qCT-Based Osteoporosis and Osteopenia Screening in Patients Undergoing Lumbar Fusion Surgery? Spine · 16 Jun 2026 PMID 42302175
- Computed tomography-measured trabecular attenuation at first lumbar vertebra as a surrogate marker of bone mineral density and osteoporosis in patients undergoing hemodialysis. Renal failure · 20 May 2026 PMID 42161888
Human data, design not indexed (3)
- OsteoNet-X: A deep residual learning framework for automated osteoporosis detection from knee X-ray images. PloS one · 27 Oct 2026 PMID 42945347
- Explainable Plasma Proteomics-Based Machine Learning for Osteoporosis Diagnosis, Prognosis, and Protein Biomarker Discovery in the UK Biobank. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 29 Aug 2026 PMID 42667149
- Osteoporosis treatment with biosimilars in Malaysia and Thailand: a budget impact analysis. Archives of osteoporosis · 13 Aug 2026 PMID 42593584
Preclinical: animal, cell and lab studies (2)
- Naringin attenuates orchidectomy-induced bone loss in male rats: evidence from bone remodeling and telomere-related indices. Journal of molecular histology · 10 Sept 2026 PMID 42717104
- Engineering Bone-Targeted LNP Delivery of Anti-Sclerostin Antibody mRNA for the Treatment of Osteoporosis. Journal of biomedical materials research. Part A · 24 Jun 2026 PMID 42338194
Unclassified: not yet indexed with MeSH (2)
- BHOD: a bone health optimized dietary pattern designed for osteoporosis prevention. NPJ science of food · 1 Jul 2026 PMID 42386741
- Identification of Chronic Stress-Related Biomarkers for Potential Diagnosis and Treatment of Osteoporosis: An Integrated Multi-omic and Clinical Data Analysis. Therapeutic innovation & regulatory science · 9 Jun 2026 PMID 42265416
Written from 10 PubMed abstracts, each one listed by PMID above. Published: 2026-08-20. Drafted by language models from published abstracts; not medical advice.